Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer
Clinical trial NCT06743581 · RECRUITING
Trial details
- NCT number
- NCT06743581
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-19
- Primary completion
- 2027-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.